Diagnositc and Prognostic Role of 68GA-DOTATATE PET in Patients with Neuroendocrine Tumors

被引：0
|
作者：
Marciello, F. [1 ]
Faggiano, A. [2 ]
Aloi, L. [2 ]
Caraco, C. [2 ]
Ramundo, V [1 ]
Marotta, V [1 ]
Del Prete, M. [1 ]
Carrat, A. C. [1 ]
Colao, A. [1 ]
La Storia, S. [2 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
[2] Natl Canc Inst Fdn G Pascale, Naples, Italy
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
68-ga-dotatate pet; octreoscan; diagnosis; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [1] The Role of 68Ga-DOTATATE PET/CT in Suspected Neuroendocrine Tumors
    Haug, Alexander R.
    Cindea-Drimus, Ramona
    Auernhammer, Christoph J.
    Reincke, Martin
    Waengler, Bjoern
    Uebleis, Christopher
    Schmidt, Gerwin P.
    Goeke, Burkhard
    Bartenstein, Peter
    Hacker, Marcus
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (11) : 1686 - 1692
  • [2] The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy
    Srirajaskanthan, Rajaventhan
    Kayani, Irfan
    Quigley, Anne Marie
    Soh, Jade
    Caplin, Martyn E.
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (06) : 875 - 882
  • [3] Should 68Ga-DOTATATE PET/CT be Performed Routinely in Patients with Neuroendocrine Tumors Before Surgical Resection?
    Babazadeh, Nasim T.
    Schlund, Devan J.
    Cornelius, Tyler
    Singh, Jagadeesh S.
    Tierney, John F.
    Chen, Meri
    Keutgen, Xavier M.
    WORLD JOURNAL OF SURGERY, 2020, 44 (02) : 604 - 611
  • [4] Impact of 68Ga-DOTATATE PET/CT on the Surgical Management of Primary Neuroendocrine Tumors of the Pancreas or Ileum
    Ilhan, Harun
    Fendler, Wolfgang P.
    Cyran, Clemens C.
    Spitzweg, Christine
    Auernhammer, Christoph J.
    Gildehaus, Franz-Josef
    Bartenstein, Peter
    Angele, Martin K.
    Haug, Alexander R.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (01) : 164 - 171
  • [5] Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
    Panagiotidis, Emmanouil
    Alshammari, Alshaima
    Miehopoulou, Sofia
    Skoura, Evangelia
    Naik, Keval
    Maragkoudakis, Emmanouil
    Mohmaduvesh, Mullan
    Al-Harbi, Mohammed
    Belda, Maria
    Caplin, Martyn E.
    Toumpanakis, Christos
    Bomanji, Jamshed
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (01) : 91 - 96
  • [6] 68Ga-DOTATATE PET/CT in Pituitary Carcinoma
    Kaya, Gursan
    Soydas Turan, Basak
    Dagdelen, Selcuk
    Berker, Mustafa
    Tuncel, Murat
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : 996 - 998
  • [7] Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
    Toriihara, Akira
    Baratto, Lucia
    Nobashi, Tomomi
    Park, Sonya
    Hatami, Negin
    Davidzon, Guido
    Kunz, Pamela L.
    Iagaru, Andrei
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) : 2244 - 2251
  • [8] Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumors
    Akira Toriihara
    Lucia Baratto
    Tomomi Nobashi
    Sonya Park
    Negin Hatami
    Guido Davidzon
    Pamela L. Kunz
    Andrei Iagaru
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2244 - 2251
  • [9] The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors A Classification System With Prognostic Impact
    Hayes, Aimee R.
    O'Mahony, Luke Furtado
    Quigley, Ann-Marie
    Gnanasegaran, Gopinath
    Caplin, Martyn E.
    Navalkissoor, Shaunak
    Toumpanakis, Christos
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : 26 - 35
  • [10] Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT
    Ma, Jiao
    Wang, Xiaoyong
    Tang, Mingsong
    Zhang, Chunyin
    ENDOCRINE, 2024, 83 (02) : 502 - 510
12345